Rinko Ghosh

Biography

 Rinko Ghosh joined Symic Bio in January 2016.  He has 20 years of experience in biotechnology and healthcare.  Previously he was Senior Vice President & Chief Business Officer at Nektar Therapeutics.  His primary responsibilities at Nektar included business and corporate development, marketing, strategic planning, portfolio evaluation and alliance management.  He has been an Advisor to several Life Sciences companies, including Epic Sciences, PulmoKine, MannKind, Pearl Therapeutics (acquired by Astra Zeneca), and Aviron (acquired by MedImmune). Prior to joining Nektar in 2001 he was co-CEO of a biotechnology startup in Asia.  Earlier, as a management consultant with A.T. Kearney in San Francisco, and as a scientific consultant with Environ Corp. in Princeton, he worked with multi-national clients in healthcare and other industries.  Mr. Ghosh earned his MBA from Wharton, his MS in Engineering from Vanderbilt University, and his BS in Engineering from the IIT, Bombay.  

Research Interest

 biotechnology and healthcare